close

Thank you

 

Sign up to receive updates from the Gates Foundation

Privacy Policy
Bill & Melinda Gates Foundation
Authors / Biography
SanicasMelvin_db

Melvin Sanicas

Title Global Health Fellow | Program Officer
Organization Bill and Melinda Gates Foundation

Dr Melvin Sanicas, a public health physician and vaccinologist, is a Program Officer and Global Health Fellow at the Bill & Melinda Gates Foundation. He is also the Program Manager of the Collaboration for TB Vaccine Discovery (CTVD). Melvin’s professional experience spans the globe - he has been involved in different stages of drug and vaccine development including regulatory affairs and pharmacovigilance in Asia Pacific while working for the national regulatory authority in Singapore, clinical trials in Italy and Southern Europe while working at Novartis Vaccines and medical-scientific affairs while working at GlaxoSmithKline. Melvin holds a Bachelor’s degree, Major in Biology (cum laude), an MD from the University of the Philippines, and postgraduate degrees in Health Economics, Patient Safety and Clinical Risk Management. He finished a Master of Science (MSc) in Infectious Diseases from the London School of Hygiene and Tropical Medicine and an Executive MSc (laurea specialistica) in Vaccinology and Pharmaceutical Clinical Development (cum laude) from the Universita degli Studi di Siena in Italy. He is a member of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), a Fellow of the Royal Society of Tropical Medicine and Hygiene (RSTMH), and a Fellow of the Royal Society for Public Health (RSPH). Melvin is an avid traveler and has been to 46 countries (and counting!). He can speak several languages with native proficiency in English, Filipino and a few Philippine dialects, and elementary proficiency in Bahasa Malay, Italian, German, and Spanish.

Posts By Melvin Sanicas

Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial

Researchers from MedUni Vienna, in collaboration with Biomedizinische Forschungsgesellschaft mbH in Vienna, have developed the world's first vaccine against Toxic Shock Syndrome (TSS) and successfully tested it in a Phase I trial.

Full Blog Post

Details

TB beats HIV as the leading infectious disease cause of death worldwide

TB for the first time surpassed HIV in total deaths per year with 1.5 million people dying from TB in 2014 (with 400,000 of those HIV positive) and 1.2 million per year dying from HIV. To end the global TB epidemic, better detection systems need to be in place and tools developed to better diagnose people, and a better vaccine should be developed.

Full Blog Post

Details

Dengue fever is now a vaccine-preventable disease!

Dengue is the fastest growing mosquito-borne disease in the world today, causing nearly 400 million infections every year. Today (in countries where the vaccine is approved), mosquito control strategies such as habitat reduction and spraying insecticide can now be supplemented by vaccination.

Full Blog Post

Details

CTVD: International network for innovation, cooperation, and collaboration in TB vaccine discovery

The Collaboration for TB Vaccine Discovery (CTVD) is an international network of scientists and experts dedicated to fostering innovation, cooperation, and collaboration in the up-stream TB vaccine discovery space.

Full Blog Post

Details